Italy Gene Therapy Market to 2032
Overview
The Italy Gene Therapy Market is expected to reach a 1,182.18 USD Billion by 2032 and is projected to grow at a CAGR of 25.61% from 2025 to 2032.
Revenue, 2024 (USD Billion)
328.42
Forecast, 2032 (USD Billion)
1,182.18
CAGR, 2024 - 2032
25.61%
Report Coverage
Italy
Italy Gene Therapy Market 2018-2032 USD Billion
Italy Gene Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 328.42 USD Billion
- Projected Market Size (2032): 1,182.18 USD Billion
- CAGR (2025-2032): 25.61%
Key Findings of Italy Gene Therapy Market
- The Italy Gene Therapy Market was valued at 328.42 USD Billion in 2024.
- The Italy Gene Therapy Market is likely to grow at a CAGR of 25.61% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Viral Vector in Vector Segment accounted for the largest share of the market with a revenue of 256.18 USD Billion
- The fastest growing segment Oncological Disorders in Application Segment grew Fastest with a CAGR of 28.62% during the forecast period from 2024 to 2032.
Italy Gene Therapy Market Scope
Italy Gene Therapy Market Segmentation & Scope
Vector
- Non-Viral Vector
- Viral Vector
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Infectious Disease
- Oncological Disorders
Method
- In-Vivo
- Ex-Vivo
Italy Gene Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 328.42 USD Billion |
| Market Value in 2032 | 1,182.18 USD Billion |
| CAGR (2025-2032) | 25.61% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Vector,End User,Application,Method |
Regional Insights:
-
Leading Market (2024-2032): Italy, leading in terms of revenue 328.42 USD Billion in 2024
- Key Country: Italy, leading in terms of revenue with value of 328.42 USD Billion in 2024.
Segments and Scope
-
Italy Gene Therapy Market to 2032, By Vector
- Viral Vector is the largest segment in Italy Gene Therapy Market to 2032 with a revenue of 256.18 USD Billion in the year 2024.
- Viral Vector is the Fastest growing segment in Italy Gene Therapy Market to 2032 with a Growth rate of 26.81 % in forecast period 2025-2032.
-
Italy Gene Therapy Market to 2032, By End User
- Cancer Institutes is the largest segment in Italy Gene Therapy Market to 2032 with a revenue of 145.36 USD Billion in the year 2024.
- Cancer Institutes is the Fastest growing segment in Italy Gene Therapy Market to 2032 with a Growth rate of 27.37 % in forecast period 2025-2032.
-
Italy Gene Therapy Market to 2032, By Application
- Oncological Disorders is the largest segment in Italy Gene Therapy Market to 2032 with a revenue of 153.74 USD Billion in the year 2024.
- Oncological Disorders is the Fastest growing segment in Italy Gene Therapy Market to 2032 with a Growth rate of 28.62 % in forecast period 2025-2032.
-
Italy Gene Therapy Market to 2032, By Method
- Ex-Vivo is the largest segment in Italy Gene Therapy Market to 2032 with a revenue of 250.27 USD Billion in the year 2024.
- Ex-Vivo is the Fastest growing segment in Italy Gene Therapy Market to 2032 with a Growth rate of 26.78 % in forecast period 2025-2032.
Italy Gene Therapy Market Company Share Analysis
| Company Name |
|
||
| Oxford Biomedica | |||
| Novartis AG | |||
| Kite Pharma Inc. | |||
| Biogen | |||
| Bristol-Myers Squibb Company | |||
Italy Gene Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion
Italy Gene Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Italy Gene Therapy Market is segmented based on Segmentation Vector,End User,Application,Method.
Italy Gene Therapy Market was valued at USD 328.42(Revenue in USD Billion) in 2021.
Italy Gene Therapy Market is projected to grow at a CAGR of 25.61% during the forecast period of 2024 to 2032.
The Viral Vector segment is expected to dominate the Italy Gene Therapy Market, holding a largest market share of 256.18 USD Billion in 2024
Italy Gene Therapy Market Scope
Italy Gene Therapy Market Segmentation & Scope
Vector
- Non-Viral Vector
- Viral Vector
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Infectious Disease
- Oncological Disorders
Method
- In-Vivo
- Ex-Vivo
Frequently Asked Questions
The Italy Gene Therapy Market is segmented based on Segmentation Vector,End User,Application,Method.
Italy Gene Therapy Market was valued at USD 328.42(Revenue in USD Billion) in 2021.
Italy Gene Therapy Market is projected to grow at a CAGR of 25.61% during the forecast period of 2024 to 2032.
The estimated market value of the Italy Gene Therapy Market for final year is USD 1,182.18 (USD Billion).
Italy Gene Therapy Market Company Profiling
Frequently Asked Questions
The Italy Gene Therapy Market is segmented based on Segmentation Vector,End User,Application,Method.
Italy Gene Therapy Market was valued at USD 328.42(Revenue in USD Billion) in 2021.
Italy Gene Therapy Market is projected to grow at a CAGR of 25.61% during the forecast period of 2024 to 2032.
The estimated market value of the Italy Gene Therapy Market for final year is USD 1,182.18 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.